LYMPHOMATOID PAPULOSIS
Clinical trials for LYMPHOMATOID PAPULOSIS explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMATOID PAPULOSIS trials appear
Sign up with your email to follow new studies for LYMPHOMATOID PAPULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a lower dose of this cancer drug be just as effective?
Disease control Recruiting nowThis study tests a lower dose of the drug brentuximab vedotin in people with mycosis fungoides, Sezary syndrome, or lymphomatoid papulosis—types of lymphoma that affect the skin. The goal is to see if the lower dose can still control the disease while causing fewer side effects. …
Matched conditions: LYMPHOMATOID PAPULOSIS
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Researchers track long-term effects of rare childhood skin lymphomas
Knowledge-focused Recruiting nowThis study follows 100 people who were diagnosed with juvenile-onset mycosis fungoides or lymphomatoid papulosis before age 20. Researchers will check their health status and ask about long-term outcomes. The goal is to understand the safety and long-term effects of these rare sk…
Matched conditions: LYMPHOMATOID PAPULOSIS
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Scientists launch tissue collection to unlock lymphoma mysteries
Knowledge-focused Recruiting nowThis study collects and stores tissue samples from people with cutaneous T-cell lymphoma (CTCL) and healthy volunteers. Researchers will use these samples to study how T cells change in CTCL. No treatment is given—the goal is to build a resource for future research. Up to 400 par…
Matched conditions: LYMPHOMATOID PAPULOSIS
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC